Frankfurt for 2013 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Frankfurt for 2013


Next year will see CPhI Worldwide and its collocated events, ICSE, P-MEC and InnoPack return to Frankfurt (Germany). The event is due to take place at the Messe Frankfurt on 22–24 October so keep the dates free!

Frankfurt first hosted CPhI in 1990; indeed, it was the location of the first ever CPhI trade show, attracting 16 exhibitors and 250 delegates as a specialist event dedicated to ingredients and intermediates. Frankfurt has been a regular venue for the show ever since and last played host to CPhI in 2011. The 2011 event was a record year for the organisers with 2,200 exhibitors and around 29,920 attendees.

“We experienced a phenomenal response to the 2011 events and this has influenced our decision to return to Messe Frankfurt in 2013,” said UBM Live Pharma Portfolio Director Greg Kerwin, in a statement. “Frankfurt has traditionally been one of the most popular venues in the events’ 22 year history, not only as a result of it being located in one of Europe’s largest pharmaceutical hubs, but due to its international accessibility, quality and availability of accommodation, and the high standards of service offered by the venue.”

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here